Skip to content

EXOZ EXOZ Accrued Expenses

Accrued Expenses at other companies

Ginkgo Bioworks logo
Ginkgo BioworksDNA
$48.38M-31.6%
NAG
Niagen Bioscience, Inc. Common StockNAGE
$7.62M-15.8%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$25.39M+2.1%
Opko Health logo
Opko HealthOPK
$83.48M-26.3%
Upexi logo
UpexiUPXI
$2.17M+869%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's accrued expenses?
EXOZ (EXOZ) reported accrued expenses of $13.41K in Q1 2026.
How has EXOZ's accrued expenses changed year-over-year?
EXOZ's accrued expenses decreased by 90.1% year-over-year, from $135.71K to $13.41K.
What is the long-term trend for EXOZ's accrued expenses?
Over 2 years (2023 to 2025), EXOZ's accrued expenses has grown at a -89.1% compound annual growth rate (CAGR), from $445.13K to $5.33K.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.